ARSENIC TRIOXIDE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where ARSENIC TRIOXIDE was used for Neoplasm malignant.
Most Reported Side Effects for ARSENIC TRIOXIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Differentiation syndrome | 180 | 15.3% | 14 | 87 |
| Electrocardiogram qt prolonged | 148 | 12.6% | 5 | 42 |
| Off label use | 128 | 10.9% | 8 | 61 |
| Acute promyelocytic leukaemia differentiation syndrome | 51 | 4.3% | 18 | 16 |
| Hyperleukocytosis | 49 | 4.2% | 1 | 26 |
| Drug ineffective | 45 | 3.8% | 21 | 15 |
| Acute kidney injury | 42 | 3.6% | 9 | 26 |
| Leukaemia recurrent | 41 | 3.5% | 16 | 1 |
| Hypokalaemia | 40 | 3.4% | 1 | 21 |
| Idiopathic intracranial hypertension | 38 | 3.2% | 3 | 2 |
| Pericarditis | 34 | 2.9% | 0 | 21 |
| Neutropenia | 33 | 2.8% | 6 | 4 |
| White blood cell count increased | 32 | 2.7% | 0 | 1 |
| Diarrhoea | 30 | 2.6% | 0 | 20 |
| Anaemia | 28 | 2.4% | 2 | 3 |
Other Indications for ARSENIC TRIOXIDE
Acute promyelocytic leukaemia (763)
Acute myeloid leukaemia (111)
Product used for unknown indication (89)
Acute leukaemia (18)
Colorectal cancer metastatic (15)
Leukaemia recurrent (13)
Plasma cell myeloma (13)
Ewing's sarcoma (12)
Neuroblastoma (10)
Adult t-cell lymphoma/leukaemia (7)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)